Valuation: Cogstate Limited

Market Cap 62Cr 43Cr 39Cr 36Cr 32Cr 61Cr 4.08TCr 427.91Cr 167.91Cr 2.15TCr 162.28Cr 158.9Cr 6.84TCr P/E 2027 *
28.3x
P/E 2028 * 22x
Enterprise Value 55Cr 39Cr 34Cr 32Cr 29Cr 54Cr 3.65TCr 382.78Cr 150.19Cr 1.92TCr 145.16Cr 142.14Cr 6.12TCr EV / Sales 2027 *
5.05x
EV / Sales 2028 * 4.25x
Free-Float
56.43%
Yield 2027 *
1.4%
Yield 2028 * 1.71%
1 day-0.28%
1 week-1.92%
Current month+4.69%
1 month+5.93%
3 months+31.73%
6 months+50.63%
Current year+57.96%
1 week 3.24
Extreme 3.24
3.73
1 month 3.23
Extreme 3.23
3.98
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Buy

Director

3,600 0.0021%
20/05/26 Buy

Director

430 0.0003%
15/04/26
Myer & Myer Pty Ltd.
SellCompany 99,74,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-1.92%+40.55%+155.00% 42Cr
-0.21%-6.36%+49.00%+74.13% 6.63TCr
-0.22%+6.53%+11.68%+87.32% 5.29TCr
+0.82%+5.41%+8.05%+73.53% 5.48TCr
+3.28%+5.58%+26.51%+50.05% 4.41TCr
+0.51%+9.95%+22.40%+133.92% 4.37TCr
-1.15%+0.39%+263.21%+594.60% 4.21TCr
+0.10%+9.96%+17.15%+59.33% 3.4TCr
-1.30%-3.61%+37.37%+7.16% 2.62TCr
+0.69%+6.07%+31.89%+26.94% 2.34TCr
Average +0.22%+3.87%+50.78%+126.20% 3.88TCr
Weighted average by Cap. +0.32%+4.98%+51.22%+127.80%

Financials

2027 *2028 *
Net sales 11Cr 7.66Cr 6.83Cr 6.32Cr 5.72Cr 11Cr 722.89Cr 76Cr 30Cr 379.98Cr 29Cr 28Cr 1.21TCr 13Cr 8.81Cr 7.85Cr 7.27Cr 6.58Cr 12Cr 831.29Cr 87Cr 34Cr 436.96Cr 33Cr 32Cr 1.39TCr
Net income 2.18Cr 1.53Cr 1.36Cr 1.26Cr 1.14Cr 2.15Cr 144.53Cr 15Cr 5.94Cr 76Cr 5.75Cr 5.63Cr 242.08Cr 2.78Cr 1.95Cr 1.74Cr 1.61Cr 1.46Cr 2.74Cr 184.15Cr 19Cr 7.57Cr 97Cr 7.32Cr 7.17Cr 308.44Cr
Net Debt -6.49Cr -4.56Cr -4.07Cr -3.76Cr -3.41Cr -6.42Cr -430.6Cr -45Cr -18Cr -226.34Cr -17Cr -17Cr -721.23Cr -8.25Cr -5.8Cr -5.17Cr -4.78Cr -4.33Cr -8.16Cr -547.14Cr -57Cr -23Cr -287.59Cr -22Cr -21Cr -916.43Cr
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
22/26/22 A$3.570 -0.28% 2,19,281
21/26/21 A$3.580 +2.29% 1,06,591
20/26/20 A$3.500 -0.85% 7,25,189
19/26/19 A$3.530 -3.29% 3,64,589
16/26/16 A$3.650 +3.40% 1,96,076
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.580AUD
Average target price
4.497AUD
Spread / Average Target
+25.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited